Business ❯ Pharmaceutical Industry

Market Trends

Drug Pricing Pricing Strategies Drug Development Stock Performance Sales Performance Weight Loss Drugs Drug Sales Generic Drugs Novo Nordisk Product Launches

Oral GLP‑1 Approval and New Trials Push Weight‑Loss Drugs Into Mass Market

Pill approvals and large sales forecasts are accelerating global uptake while tightening coverage and exposing safety and long‑term care gaps.

Mounjaro Overtakes Keytruda as World’s Best-Selling Drug in Q1 2026

DOJ Moves State-Licensed Medical Marijuana to Schedule III Ahead of June DEA Hearing

Gurugram Bust Seizes 242 Suspected Fake Mounjaro Pens, Two Arrested

India’s ‘Mounjaro Bride’ Trend Fuels Pre‑Wedding Use of GLP‑1 Weight‑Loss Shots

Spyre Drug Meets Midstage Target in Ulcerative Colitis, Stock Rallies

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Amazon Pharmacy Launches Same-Day Delivery for Lilly’s Foundayo Weight-Loss Pill

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

Generics Flood India After Semaglutide Patent Lapses, Slashing Prices Up to 90%

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

Brazil's Semaglutide Patent Expires Friday, Opening Door to Ozempic Generics

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

India Warns Drugmakers Over Indirect Promotion of GLP‑1 Weight‑Loss Drugs

FDA Maps New Paths for Rare-Disease Drug Evidence, Keeps Bar High

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Wegovy Pill Posts Strong U.S. Debut as U.K. Authorizes Higher 7.2 mg Injectable Dose

Next-Generation Obesity Treatments Gain Traction in 2026 as Brazil Nears Semaglutide Patent Lapse

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

GSK and Ionis Report Phase 3 Success for Hepatitis B Drug, Plan Q1 Filings